The U.S. Food and Drug Administration is refusing to consider Moderna’s application for a new flu vaccine made with mRNA ...

LONDON, Feb 13 (Reuters) - Vaccines are a matter of national security, a leading global health figure said this week, warning that rising anti-vaccine sentiment worldwide could undermine efforts to ...

Moderna stock was a highflier in early pandemic days as sales of its coronavirus vaccine soared.

Shinzo Abe was no longer prime minister of Japan when the country first authorised COVID-19 vaccines, contrary to misleading ...

In an interview, Moderna President Stephen Hoge took questions on an FDA decision on the biotech's mRNA flu vaccine, as well ...

The move is further in line with HHS Secretary Kennedy's anti-vaccine policies ...

The F.D.A.’s refusal to examine the company’s mRNA shot drew widespread criticism from doctors and was divisive within the agency.

The Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with mRNA technology, the company said.

This week, vaccine manufacturer Moderna revealed that Vinaya Prasad, the top vaccine regulator at the Food and Drug Administration (FDA)—which is a part of HHS— declined to even consider the safety ...

In a rare and surprising move, the FDA has issued a “Refusal to File” letter for Moderna’s mRNA-1010 influenza vaccine.